X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-03 | ADPT | Adaptive Biotechnologies Corp | Griffin Michelle Renee | Dir | S - Sale+OE | $15.30 | -48,044 | 15,394 | -76% | -$735,073 | |||||
| DM | 2026-03-03 | ADPT | Adaptive Biotechnologies Corp | Rubinstein Julie | Pres, COO | S - Sale+OE | $16.09 | -92,823 | 575,235 | -14% | -$1,493,428 | |||||
| D | 2026-03-04 | LONA | Leonabio, Inc. | Litton Mark James | Pres, CEO | S - Sale+OE | $5.37 | -5,156 | 59,894 | -8% | -$27,688 | |||||
| D | 2026-03-04 | LONA | Leonabio, Inc. | Renninger Robert | CFO | S - Sale+OE | $5.37 | -906 | 15,851 | -5% | -$4,865 | |||||
| D | 2026-03-04 | LONA | Leonabio, Inc. | Worthington Mark | GC, CCO | S - Sale+OE | $5.37 | -1,328 | 18,376 | -7% | -$7,131 | |||||
| D | 2026-03-04 | LONA | Leonabio, Inc. | Church Kevin | CHIEF SCIENTIFIC OFFICER | S - Sale+OE | $5.37 | -1,359 | 25,178 | -5% | -$7,298 | |||||
| D | 2026-03-04 | LONA | Leonabio, Inc. | San Martin Javier | CHIEF MEDICAL OFFICER | S - Sale+OE | $5.37 | -1,720 | 15,887 | -10% | -$9,236 | |||||
| DM | 2026-03-03 | TECX | Tectonic Therapeutic, Inc. | McNamara Peter | Chief Scientific Officer | S - Sale+OE | $23.53 | -3,299 | 58,832 | -5% | -$77,627 | |||||
2026-03-04 | GLUE | Monte Rosa Therapeutics, Inc. | Dunn Edmund | Principal Accounting Officer | S - Sale | $17.96 | -139 | 22,554 | -1% | -$2,496 | ||||||
| A | 2026-02-11 | TECX | Tectonic Therapeutic, Inc. | Reicin Alise | CEO | P - Purchase | $21.10 | +2,500 | 362,077 | +1% | +$52,750 | |||||
2026-03-04 | TARS | Tarsus Pharmaceuticals, Inc. | Neervannan Seshadri | COO | S - Sale | $76.67 | -8,366 | 71,292 | -11% | -$641,421 | ||||||
2026-03-02 | APGE | Apogee Therapeutics, Inc. | Henderson Jane | CFO | S - Sale | $70.22 | -2,000 | 181,371 | -1% | -$140,431 | ||||||
| M | 2026-03-02 | ADPT | Adaptive Biotechnologies Corp | Robins Harlan S | Chief Scientific Officer | S - Sale | $16.19 | -24,233 | 1,155,291 | -2% | -$392,329 | |||||
| DM | 2026-03-02 | HALO | Halozyme Therapeutics, Inc. | Torley Helen | Pres, CEO | S - Sale+OE | $69.52 | -50,000 | 767,780 | -6% | -$3,476,157 | |||||
| DM | 2026-03-02 | KYMR | Kymera Therapeutics, Inc. | Chadwick Jeremy G | COO | S - Sale+OE | $86.54 | -5,958 | 73,810 | -7% | -$515,594 | |||||
| DM | 2026-03-02 | KYMR | Kymera Therapeutics, Inc. | Gollob Jared | Chief Medical Officer | S - Sale+OE | $87.24 | -10,508 | 117,134 | -8% | -$916,669 | |||||
| DM | 2026-03-02 | KYMR | Kymera Therapeutics, Inc. | Jacobs Bruce N. | CFO | S - Sale+OE | $87.50 | -12,471 | 232,588 | -5% | -$1,091,231 | |||||
2026-03-02 | ALLO | Allogene Therapeutics, Inc. | Beneski Benjamin Machinas | SVP, Chief Technical Officer | S - Sale | $2.60 | -7,132 | 203,040 | -3% | -$18,543 | ||||||
2026-03-03 | EDIT | Editas Medicine, Inc. | O'Neill Gilmore Neil | CEO | S - Sale | $2.02 | -5,394 | 263,693 | -2% | -$10,894 | ||||||
2026-03-02 | GLUE | Monte Rosa Therapeutics, Inc. | Warmuth Markus | Pres, CEO | S - Sale | $17.92 | -5,466 | 613,471 | -1% | -$97,974 | ||||||
2026-03-03 | EDIT | Editas Medicine, Inc. | Parison Amy | SVP, CFO | S - Sale | $2.02 | -474 | 15,434 | -3% | -$957 | ||||||
2026-03-03 | EDIT | Editas Medicine, Inc. | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | S - Sale | $2.02 | -749 | 68,028 | -1% | -$1,513 | ||||||
| M | 2026-02-27 | INKT | Mink Therapeutics, Inc. | Ryan Barbara | Dir | S - Sale | $10.85 | -500 | 21,906 | -2% | -$5,426 | |||||
2026-03-03 | RXRX | Recursion Pharmaceuticals, Inc. | Borgeson Blake | Dir | S - Sale | $3.46 | -170,000 | 6,259,863 | -3% | -$588,200 | ||||||
2026-03-02 | KYMR | Kymera Therapeutics, Inc. | Booth Bruce | Dir | S - Sale | $90.13 | -81,866 | 675,341 | -11% | -$7,378,583 | ||||||
2026-03-02 | ATRA | Atara Biotherapeutics, Inc. | Grant-Huerta Yanina | Chief Accounting Officer | S - Sale | $5.08 | -2,104 | 31,750 | -6% | -$10,691 | ||||||
2026-03-02 | ATRA | Atara Biotherapeutics, Inc. | Nguyen Anhco | Pres, CEO | S - Sale | $5.09 | -2,996 | 61,978 | -5% | -$15,237 | ||||||
| D | 2026-03-02 | VCEL | Vericel Corp | Flynn Sean C. | GC | S - Sale+OE | $35.18 | -21,421 | 1,262 | -94% | -$753,530 | |||||
| M | 2026-03-02 | ACOG | Alpha Cognition Inc. | Opaleye Management Inc. | 10% | P - Purchase | $5.76 | +71,411 | 2,440,049 | +3% | +$411,624 | |||||
2026-03-02 | VCEL | Vericel Corp | Halpin Michael | COO | S - Sale | $35.30 | -10,305 | 16,080 | -39% | -$363,767 | ||||||
| D | 2026-02-27 | ABOS | Acumen Pharmaceuticals, Inc. | Meisner Derek M | GC, Corp Sec | S - Sale+OE | $3.01 | -9,406 | 173,999 | -5% | -$28,311 | |||||
| D | 2026-03-02 | RVMD | Revolution Medicines, Inc. | Goldsmith Mark A | See Remarks | S - Sale+OE | $101.23 | -36,000 | 948,053 | -4% | -$3,644,354 | |||||
| M | 2026-02-27 | ADPT | Adaptive Biotechnologies Corp | Robins Chad M | CEO, COB | S - Sale | $15.85 | -524,998 | 1,934,247 | -21% | -$8,320,613 | |||||
| D | 2026-03-02 | KRYS | Krystal Biotech, Inc. | Romano Kathryn | Chief Accounting Officer | S - Sale+OE | $267.60 | -750 | 22,366 | -3% | -$200,700 | |||||
2026-02-27 | KRYS | Krystal Biotech, Inc. | Janney Daniel | Dir | S - Sale | $275.59 | -11,803 | 73,293 | -14% | -$3,252,824 | ||||||
2026-03-03 | ALEC | Alector, Inc. | Wong-Sarad Grace | Principal Accounting Officer | S - Sale | $2.08 | -3,367 | 107,465 | -3% | -$7,012 | ||||||
| D | 2026-03-02 | MRNA | Moderna, Inc. | Klinger Shannon Thyme | GC | S - Sale+OE | $52.29 | -13,885 | 59,689 | -19% | -$726,047 | |||||
2026-02-27 | ZIVO | Zivo Bioscience, Inc. | Yaldoo Laith L | Dir, 10% | P - Purchase | $9.72 | +1,543 | 583,615 | 0% | +$14,998 | ||||||
2026-03-02 | ALEC | Alector, Inc. | Wong-Sarad Grace | Principal Accounting Officer | S - Sale | $2.12 | -8,071 | 110,832 | -7% | -$17,138 | ||||||
2026-03-02 | ALEC | Alector, Inc. | Rosenthal Arnon | CEO | S - Sale | $2.12 | -81,864 | 6,268,551 | -1% | -$173,822 | ||||||
2026-03-02 | ALEC | Alector, Inc. | Berkley Neil Lindsay | CFO, Chief Business Officer | S - Sale | $2.12 | -29,649 | 344,660 | -8% | -$62,954 | ||||||
| D | 2026-03-02 | FENC | Fennec Pharmaceuticals Inc. | Raykov Rosty | Dir | S - Sale+OE | $8.36 | -10,079 | 109,204 | -8% | -$84,260 | |||||
2026-03-02 | VIR | Vir Biotechnology, Inc. | Sato Vicki L | Dir | S - Sale | $9.51 | -22,000 | 1,122,391 | -2% | -$209,181 | ||||||
| D | 2026-02-26 | AMGN | Amgen Inc | Santos Esteban | EVP, Operations | S - Sale+OE | $379.12 | -54,792 | 77,522 | -41% | -$20,772,595 | |||||
2026-02-26 | ZURA | Zura Bio Ltd | Ai Biotechnology LLC | 10% | P - Purchase | $6.25 | +2,000,000 | 6,552,725 | +44% | +$12,500,000 | ||||||
| DM | 2026-02-27 | GLUE | Monte Rosa Therapeutics, Inc. | Dunn Edmund | Principal Accounting Officer | S - Sale+OE | $18.09 | -25,700 | 22,693 | -53% | -$464,886 | |||||
2026-02-27 | GILD | Gilead Sciences, Inc. | O'Day Daniel Patrick | COB, CEO | S - Sale | $144.79 | -10,000 | 642,308 | -2% | -$1,447,859 | ||||||
| M | 2026-02-26 | ACOG | Alpha Cognition Inc. | Opaleye Management Inc. | 10% | P - Purchase | $5.99 | +4,228 | 2,368,638 | 0% | +$25,328 | |||||
2026-02-27 | ACLX | Arcellx, Inc. | Elghandour Rami | SEE REMARKS | S - Sale | $113.92 | -89,916 | 692,551 | -11% | -$10,243,267 | ||||||
2026-02-25 | IMVT | Immunovant, Inc. | Gloria Melanie | COO | S - Sale | $27.85 | -3,238 | 170,273 | -2% | -$90,184 | ||||||
2026-02-25 | CRBU | Caribou Biosciences, Inc. | Kelly Timothy P | CTO | S - Sale | $1.93 | -6,228 | 73,125 | -8% | -$12,020 | ||||||
2026-02-24 | IBRX | Immunitybio, Inc. | Simon Barry J. | Dir | S - Sale | $12.01 | -75,000 | 2,850,821 | -3% | -$900,788 | ||||||
2026-02-23 | CADL | Candel Therapeutics, Inc. | Manning Paul B | Dir | P - Purchase | $5.45 | +550,458 | 5,748,279 | +11% | +$2,999,996 | ||||||
| DM | 2026-02-24 | KRYS | Krystal Biotech, Inc. | Janney Daniel | Dir | S - Sale+OE | $268.44 | -60,161 | 85,096 | -41% | -$16,149,383 | |||||
2026-02-24 | EXEL | Exelixis, Inc. | Aftab Dana | EVP, Research, Development | S - Sale | $44.50 | -47,918 | 621,941 | -7% | -$2,132,351 | ||||||
2026-02-26 | ALEC | Alector, Inc. | Wong-Sarad Grace | Principal Accounting Officer | S - Sale | $2.50 | -4,079 | 118,903 | -3% | -$10,198 | ||||||
2026-02-25 | CGEM | Cullinan Therapeutics, Inc. | Michaelson Jennifer | Chief Scientific Officer | S - Sale | $14.14 | -1,780 | 174,844 | -1% | -$25,169 | ||||||
| D | 2026-02-24 | VIR | Vir Biotechnology, Inc. | Sato Vicki L | Dir | S - Sale+OE | $9.75 | -42,377 | 1,144,391 | -4% | -$413,366 | |||||
2026-02-24 | VIR | Vir Biotechnology, Inc. | Sabatini Brent | SVP, Chief Accounting Officer | S - Sale | $9.53 | -1,430 | 69,613 | -2% | -$13,632 | ||||||
2026-02-24 | VIR | Vir Biotechnology, Inc. | O'Byrne Jason | EVP, CFO | S - Sale | $9.53 | -1,634 | 162,615 | -1% | -$15,576 | ||||||
| M | 2026-02-24 | VIR | Vir Biotechnology, Inc. | Eisner Mark | EVP, Chief Medical Officer | S - Sale | $9.69 | -3,505 | 154,024 | -2% | -$33,955 | |||||
| M | 2026-02-24 | VIR | Vir Biotechnology, Inc. | De Verneuil Vanina | EVP, GC, Corp Sec | S - Sale | $9.77 | -16,817 | 112,982 | -13% | -$164,247 | |||||
2026-02-24 | VIR | Vir Biotechnology, Inc. | De Backer Marianne | CEO | S - Sale | $9.53 | -14,762 | 1,073,822 | -1% | -$140,720 | ||||||
| M | 2026-02-24 | TNYA | Tenaya Therapeutics, Inc. | Column Group III Gp, LP | 10% | S - Sale | $0.57 | -4,170,266 | 49,313,559 | -8% | -$2,380,189 | |||||
| D | 2026-02-24 | BEAM | Beam Therapeutics Inc. | Ciaramella Giuseppe | Pres | S - Sale+OE | $32.00 | -35,000 | 190,216 | -16% | -$1,120,042 | |||||
2026-02-24 | VYGR | Voyager Therapeutics, Inc. | Swartz Robin | COO, CBO | S - Sale | $3.77 | -6,458 | 199,738 | -3% | -$24,347 | ||||||
2026-02-24 | VYGR | Voyager Therapeutics, Inc. | Sandrock Alfred | Pres, CEO | S - Sale | $3.79 | -14,197 | 484,060 | -3% | -$53,807 | ||||||
2026-02-24 | VYGR | Voyager Therapeutics, Inc. | Jorgensen Nathan D. | CFO | S - Sale | $3.77 | -4,668 | 151,416 | -3% | -$17,598 | ||||||
2026-02-24 | VYGR | Voyager Therapeutics, Inc. | Carter Todd Alfred | Chief Scientific Officer | S - Sale | $3.76 | -4,174 | 145,718 | -3% | -$15,694 | ||||||
2026-02-25 | ACLX | Arcellx, Inc. | Gilson Michelle | CFO | S - Sale | $113.82 | -11,219 | 33,938 | -25% | -$1,276,954 | ||||||
2026-02-23 | SRRK | Scholar Rock Holding Corp | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | S - Sale | $47.07 | -8,484 | 98,445 | -8% | -$399,351 | ||||||
| D | 2026-02-25 | KYMR | Kymera Therapeutics, Inc. | Mainolfi Nello | CEO | S - Sale+OE | $90.26 | -30,000 | 666,195 | -4% | -$2,707,813 | |||||
| M | 2026-02-23 | CGEM | Cullinan Therapeutics, Inc. | Michaelson Jennifer | Chief Scientific Officer | S - Sale | $14.31 | -5,353 | 176,624 | -3% | -$76,617 | |||||
2026-02-24 | CGEM | Cullinan Therapeutics, Inc. | Ahmed Nadim | Pres, CEO | S - Sale | $14.47 | -13,515 | 390,803 | -3% | -$195,562 | ||||||
2026-02-24 | CGEM | Cullinan Therapeutics, Inc. | Jones Jeffrey Alan | Chief Medical Officer | S - Sale | $14.47 | -4,582 | 159,968 | -3% | -$66,302 | ||||||
2026-02-24 | CGEM | Cullinan Therapeutics, Inc. | Sumer Jacquelyn L | GC | S - Sale | $14.47 | -3,601 | 128,089 | -3% | -$52,106 | ||||||
| D | 2026-02-23 | MRNA | Moderna, Inc. | Hoge Stephen | Pres | S - Sale+OE | $48.84 | -160,009 | 1,613,476 | -9% | -$7,814,840 | |||||
2026-02-23 | TWST | Twist Bioscience Corp | Finn Patrick John | Pres, COO | S - Sale | $46.71 | -4,294 | 284,129 | -1% | -$200,572 | ||||||
2026-02-23 | TWST | Twist Bioscience Corp | Werner Robert F. | Chief Accounting Officer | S - Sale | $46.71 | -1,693 | 55,045 | -3% | -$79,080 | ||||||
2026-02-23 | TWST | Twist Bioscience Corp | Laponis Adam | CFO | S - Sale | $46.71 | -2,085 | 128,291 | -2% | -$97,390 | ||||||
| D | 2026-02-23 | TWST | Twist Bioscience Corp | Leproust Emily M. | CEO | S - Sale+OE | $46.71 | -7,205 | 863,052 | -1% | -$336,544 | |||||
2026-02-23 | TWST | Twist Bioscience Corp | Green Paula | SVP of HR | S - Sale | $46.71 | -1,465 | 125,336 | -1% | -$68,430 | ||||||
2026-02-23 | TWST | Twist Bioscience Corp | Cho Dennis | See Remarks | S - Sale | $46.71 | -844 | 138,682 | -1% | -$39,423 | ||||||
| D | 2026-02-24 | CRBU | Caribou Biosciences, Inc. | Kelly Timothy P | CTO | S - Sale+OE | $1.96 | -3,147 | 79,353 | -4% | -$6,168 | |||||
| D | 2026-02-24 | CRBU | Caribou Biosciences, Inc. | McClung Barbara G | GC | S - Sale+OE | $1.96 | -6,938 | 481,564 | -1% | -$13,598 | |||||
| D | 2026-02-24 | CRBU | Caribou Biosciences, Inc. | Khan Ruhi Ahmad | Chief Business Officer | S - Sale+OE | $1.96 | -6,938 | 104,998 | -6% | -$13,598 | |||||
| D | 2026-02-24 | CRBU | Caribou Biosciences, Inc. | Albertson Tina M. | Chief Medical Officer | S - Sale+OE | $1.96 | -1,066 | 68,523 | -2% | -$2,089 | |||||
| D | 2026-02-23 | IBRX | Immunitybio, Inc. | Selecky Christobel | Dir | S - Sale+OE | $10.00 | -25,000 | 0 | -100% | -$250,000 | |||||
| DM | 2026-02-20 | IBRX | Immunitybio, Inc. | Simon Barry J. | Dir | S - Sale+OE | $10.19 | -175,000 | 2,925,821 | -6% | -$1,783,602 | |||||
| D | 2026-02-23 | VIR | Vir Biotechnology, Inc. | Sabatini Brent | SVP, Chief Accounting Officer | S - Sale+OE | $7.45 | -1,829 | 71,043 | -3% | -$13,631 | |||||
| D | 2026-02-23 | VIR | Vir Biotechnology, Inc. | O'Byrne Jason | EVP, CFO | S - Sale+OE | $7.45 | -2,089 | 164,249 | -1% | -$15,569 | |||||
| D | 2026-02-23 | VIR | Vir Biotechnology, Inc. | Eisner Mark | EVP, Chief Medical Officer | S - Sale+OE | $7.45 | -2,089 | 157,529 | -1% | -$15,569 | |||||
| D | 2026-02-23 | VIR | Vir Biotechnology, Inc. | De Verneuil Vanina | EVP, GC, Corp Sec | S - Sale+OE | $7.45 | -4,445 | 129,799 | -3% | -$33,128 | |||||
| D | 2026-02-23 | VIR | Vir Biotechnology, Inc. | De Backer Marianne | CEO | S - Sale+OE | $7.45 | -19,039 | 1,088,584 | -2% | -$141,894 | |||||
| M | 2026-02-20 | ACOG | Alpha Cognition Inc. | Opaleye Management Inc. | 10% | P - Purchase | $5.86 | +171,410 | 2,364,410 | +8% | +$1,003,958 | |||||
| M | 2026-02-20 | TNYA | Tenaya Therapeutics, Inc. | Column Group III Gp, LP | 10% | S - Sale | $0.61 | -829,734 | 51,525,316 | -2% | -$504,787 | |||||
2026-02-23 | GLUE | Monte Rosa Therapeutics, Inc. | Janku Filip | Chief Medical Officer | S - Sale | $19.50 | -9,189 | 65,837 | -12% | -$179,161 | ||||||
| D | 2026-02-19 | KRYS | Krystal Biotech, Inc. | Rossi Dino A | Dir | S - Sale+OE | $261.41 | -18,950 | 78,691 | -19% | -$4,953,694 | |||||
2026-02-19 | EXEL | Exelixis, Inc. | Aftab Dana | EVP, Research, Development | S - Sale | $44.35 | -29,873 | 669,859 | -4% | -$1,324,868 | ||||||
2026-02-20 | CGEM | Cullinan Therapeutics, Inc. | Jones Jeffrey Alan | Chief Medical Officer | S - Sale | $13.62 | -4,982 | 164,550 | -3% | -$67,855 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |